(Q39995123)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Zoledronic acid is effective against experimental malignant pleural effusion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Georgios T. Stathopoulos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Ioannis Psallidas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Charalampos Moschos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Heleni Loutrari

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Androniki Kollintza

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sophia Karabela

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sophia Magkouta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Zongmin Zhou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Spyros A Papiris

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Charis Roussos

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Ioannis Kalomenidis

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

3 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

50-59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

Management of malignant pleural effusions

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

21 January 2018

Talc for pleurodesis?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Tumor necrosis factor-alpha promotes malignant pleural effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Recent developments in bisphosphonates for patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Clinical benefit of zoledronic acid for the prevention of skeletal complications in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

The antineoplastic role of bisphosphonates: from basic research to clinical evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Mastic oil from Pistacia lentiscus var. chia inhibits growth and survival of human K562 leukemia cells and attenuates angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

A role for Rho in Ras transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Bronchoalveolar lavage and the immunology of primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

MMP and TIMP expression pattern in pleural effusions of different origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

The inhibitory effect of alendronate, a nitrogen-containing bisphosphonate on the PI3K-Akt-NFkappaB pathway in osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200710-1513OC

10.1164/RCCM.200710-1513OC

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388351%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference